Review of therapeutic options and the management of patients with myelodysplastic syndromes
出版年份 2013 全文链接
标题
Review of therapeutic options and the management of patients with myelodysplastic syndromes
作者
关键词
-
出版物
Expert Review of Hematology
Volume 6, Issue 2, Pages 165-189
出版商
Informa UK Limited
发表日期
2013-04-03
DOI
10.1586/ehm.13.7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Myelodysplastic syndromes: 2012 update on diagnosis, risk-stratification, and management
- (2012) Guillermo Garcia-Manero AMERICAN JOURNAL OF HEMATOLOGY
- Why Are Myelodysplastic Syndromes Unrecognized and Underdiagnosed?: A Primary Care Perspective
- (2012) Awais M. Khan AMERICAN JOURNAL OF MEDICINE
- Clinical Presentation, Diagnosis, and Prognosis of Myelodysplastic Syndromes
- (2012) James M. Foran et al. AMERICAN JOURNAL OF MEDICINE
- Phase 2 study of the lenalidomide and azacitidine combination in patients with higher-risk myelodysplastic syndromes
- (2012) M. A. Sekeres et al. BLOOD
- Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: correlations with clinicobiologic parameters
- (2012) G. M. Rigolin et al. BLOOD
- Revised International Prognostic Scoring System for Myelodysplastic Syndromes
- (2012) P. L. Greenberg et al. BLOOD
- Optimizing hypomethylating agents in myelodysplastic syndromes
- (2012) Raphael Itzykson et al. CURRENT OPINION IN HEMATOLOGY
- Improvement of iron-mediated oxidative DNA damage in patients with transfusion-dependent myelodysplastic syndrome by treatment with deferasirox
- (2012) Shohei Kikuchi et al. FREE RADICAL BIOLOGY AND MEDICINE
- Outcome of patients with low-risk myelodysplasia after azacitidine treatment failure
- (2012) T. Prebet et al. HAEMATOLOGICA
- Hematologic responses to deferasirox therapy in transfusion-dependent patients with myelodysplastic syndromes
- (2012) N. Gattermann et al. HAEMATOLOGICA
- Improved survival in MDS patients receiving iron chelation therapy – A matched pair analysis of 188 patients from the Düsseldorf MDS registry
- (2012) Judith Neukirchen et al. LEUKEMIA RESEARCH
- The clinical, quality of life, and economic consequences of chronic anemia and transfusion support in patients with myelodysplastic syndromes
- (2012) Uwe Platzbecker et al. LEUKEMIA RESEARCH
- Aging of the Microenvironment Influences Clonality in Hematopoiesis
- (2012) Virag Vas et al. PLoS One
- Management of High Ferritin in Long-Term Survivors After Hematopoietic Stem Cell Transplantation
- (2012) Eolia Brissot et al. SEMINARS IN HEMATOLOGY
- Incidence of the myelodysplastic syndromes using a novel claims-based algorithm: high number of uncaptured cases by cancer registries
- (2011) C. R. Cogle et al. BLOOD
- A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q
- (2011) P. Fenaux et al. BLOOD
- An integrated analysis of germline and somatic, genetic and epigenetic alterations at 9p21.3 in glioblastoma
- (2011) Junjie Feng et al. CANCER
- Significance of Thrombocytopenia in Myelodysplastic Syndromes: Associations and Prognostic Implications
- (2011) Ali Al Ameri et al. Clinical Lymphoma Myeloma & Leukemia
- Abrogation of RUNX1 gene expression in de novo myelodysplastic syndrome with t(4;21)(q21;q22)
- (2011) A. Rio-Machin et al. HAEMATOLOGICA
- Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS)
- (2011) L. Malcovati et al. HAEMATOLOGICA
- Prognostic Significance of ASXL1 Mutations in Patients With Myelodysplastic Syndromes
- (2011) Felicitas Thol et al. JOURNAL OF CLINICAL ONCOLOGY
- Unraveling the Molecular Pathophysiology of Myelodysplastic Syndromes
- (2011) Rafael Bejar et al. JOURNAL OF CLINICAL ONCOLOGY
- How to manage lower-risk myelodysplastic syndromes
- (2011) M A Sekeres LEUKEMIA
- Update on cytogenetic and molecular changes in myelodysplastic syndromes
- (2011) Brigitte Schlegelberger et al. LEUKEMIA & LYMPHOMA
- 352 Iron overload in low-risk myelodysplastic syndromes (MDS): A multicentric study
- (2011) S. Improta et al. LEUKEMIA RESEARCH
- Clinical management of gastrointestinal disturbances in patients with myelodysplastic syndromes receiving iron chelation treatment with deferasirox
- (2011) Florian Nolte et al. LEUKEMIA RESEARCH
- The long term risk of myelodysplastic syndromes among anemia patients: A population-based study
- (2011) D. Meytes et al. LEUKEMIA RESEARCH
- Biology and treatment of the 5q- syndrome
- (2011) Eric Padron et al. Expert Review of Hematology
- Immunomodulating Drugs in Myelodysplastic Syndromes
- (2011) L. Ades et al. Hematology-American Society of Hematology Education Program
- Transfusion intensity, not the cumulative red blood cell transfusion burden, determines the prognosis of patients with myelodysplastic syndrome on chronic transfusion support
- (2010) Arturo Pereira et al. AMERICAN JOURNAL OF HEMATOLOGY
- Eltrombopag: A Novel Oral Thrombopoietin Receptor Agonist
- (2010) S. L. Corman et al. ANNALS OF PHARMACOTHERAPY
- Controversies surrounding iron chelation therapy for MDS
- (2010) Heather A. Leitch BLOOD REVIEWS
- Outcome of patients with myelodysplastic syndrome after failure of decitabine therapy
- (2010) Elias Jabbour et al. CANCER
- Myelodysplastic syndromes: A practical approach to diagnosis and treatment
- (2010) A. BARZI et al. CLEVELAND CLINIC JOURNAL OF MEDICINE
- Epigenetic Changes in the Myelodysplastic Syndrome
- (2010) Jean-Pierre Issa HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Next-Generation Sequencing Technology Reveals a Characteristic Pattern of Molecular Mutations in 72.8% of Chronic Myelomonocytic Leukemia by Detecting Frequent Alterations in TET2, CBL, RAS, and RUNX1
- (2010) Alexander Kohlmann et al. JOURNAL OF CLINICAL ONCOLOGY
- Alemtuzumab Treatment of Intermediate-1 Myelodysplasia Patients Is Associated With Sustained Improvement in Blood Counts and Cytogenetic Remissions
- (2010) Elaine M. Sloand et al. JOURNAL OF CLINICAL ONCOLOGY
- Does iron chelation therapy improve survival in regularly transfused lower risk MDS patients? A multicenter study by the GFM
- (2010) Christian Rose et al. LEUKEMIA RESEARCH
- Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study
- (2010) Norbert Gattermann et al. LEUKEMIA RESEARCH
- Early Deferasirox Treatment in a Patient with Myelodysplastic Syndrome Results in a Long-Term Reduction in Transfusion Requirements
- (2009) Silvana Capalbo et al. ACTA HAEMATOLOGICA
- Myelodysplastic Syndromes
- (2009) Attilio Orazi et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Objectives of iron chelation therapy in myelodysplastic syndromes: more than meets the eye?
- (2009) V. Pullarkat BLOOD
- Elevated pretransplant ferritin is associated with a lower incidence of chronic graft-versus-host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantation
- (2009) Anuj Mahindra et al. BRITISH JOURNAL OF HAEMATOLOGY
- Expanded safety experience with lenalidomide plus dexamethasone in relapsed or refractory multiple myeloma
- (2009) Christine Chen et al. BRITISH JOURNAL OF HAEMATOLOGY
- Platelet counts and haemorrhagic diathesis in patients with myelodysplastic syndromes
- (2009) Judith Neukirchen et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes
- (2009) A. A. van de Loosdrecht et al. HAEMATOLOGICA
- Deferasirox: An Update
- (2009) John B. Porter HEMOGLOBIN
- Safety and Efficacy of Romiplostim in Patients With Lower-Risk Myelodysplastic Syndrome and Thrombocytopenia
- (2009) Hagop Kantarjian et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
- (2009) Pierre Fenaux et al. LANCET ONCOLOGY
- Impact of transfusion dependency on survival in patients with early myelodysplastic syndrome without excess of blasts
- (2009) Jaroslav Cermak et al. LEUKEMIA RESEARCH
- P104 Change in liver iron concentration (LIC), serum ferritin (SF) and labile plasma iron (LPI) over 1 year of deferasirox (Exjade®) therapy in a cohort of patients with MDS
- (2009) P.L. Greenberg et al. LEUKEMIA RESEARCH
- P103 Iron chelation treatment in patients with myelodysplastic syndromes (MDS): the experience of the Hellenic MDS Study Group
- (2009) A. Kouraklis et al. LEUKEMIA RESEARCH
- Impact of pre-transplant serum ferritin on outcomes of patients with myelodysplastic syndromes or secondary acute myeloid leukaemia receiving reduced intensity conditioning allogeneic haematopoietic stem cell transplantation
- (2009) Z.Y. Lim et al. LEUKEMIA RESEARCH
- Differences in the distribution of subtypes according to the WHO classification 2008 between Japanese and German patients with refractory anemia according to the FAB classification in myelodysplastic syndromes
- (2009) Akira Matsuda et al. LEUKEMIA RESEARCH
- Acquired mutations in TET2 are common in myelodysplastic syndromes
- (2009) Saskia M C Langemeijer et al. NATURE GENETICS
- Myelodysplastic Syndromes
- (2009) Ayalew Tefferi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutation inTET2in Myeloid Cancers
- (2009) François Delhommeau et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment of transfusional iron overload in patients with myelodysplastic syndrome or severe anemia: data from multicenter clinical practices
- (2009) Anastasios Raptis et al. TRANSFUSION
- Supportive care and chelation therapy in MDS: are we saving lives or just lowering iron?
- (2009) H. A. Leitch et al. Hematology-American Society of Hematology Education Program
- Deferasirox Treatment Improved the Hemoglobin Level and Decreased Transfusion Requirements in Four Patients with the Myelodysplastic Syndrome and Primary Myelofibrosis
- (2008) E. Messa et al. ACTA HAEMATOLOGICA
- Consensus statement on iron overload in myelodysplastic syndromes
- (2008) John M. Bennett et al. AMERICAN JOURNAL OF HEMATOLOGY
- Epidemiology, classification and prognosis of adults and children with myelodysplastic syndromes
- (2008) Ulrich Germing et al. ANNALS OF HEMATOLOGY
- Elevated Ferritin Is Associated with Relapse after Autologous Hematopoietic Stem Cell Transplantation for Lymphoma
- (2008) Anuj Mahindra et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Red Blood Cell Transfusion Dependence and Outcome after Allogeneic Peripheral Blood Stem Cell Transplantation in Patients with de Novo Myelodysplastic Syndrome (MDS)
- (2008) Uwe Platzbecker et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Interfering RNA-mediated purine analog resistance for in vitro and in vivo cell selection
- (2008) C. C. Porter et al. BLOOD
- Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA 99 multicenter study by the PETHEMA Group
- (2008) M. A. Sanz et al. BLOOD
- Hematopoiesis is not clonal in healthy elderly women
- (2008) S. I. Swierczek et al. BLOOD
- Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs
- (2008) D. E. Rollison et al. BLOOD
- The role of iron in patients after bone marrow transplantation
- (2008) Theo de Witte BLOOD REVIEWS
- Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation
- (2008) V Pullarkat et al. BONE MARROW TRANSPLANTATION
- Genomic instability in myeloid malignancies: Increased reactive oxygen species (ROS), DNA double strand breaks (DSBs) and error-prone repair
- (2008) Annahita Sallmyr et al. CANCER LETTERS
- Myocardial iron overload assessment by T2* magnetic resonance imaging in adult transfusion dependent patients with acquired anemias
- (2008) A. A. Di Tucci et al. HAEMATOLOGICA
- Japanese epidemiological survey with consensus statement on Japanese guidelines for treatment of iron overload in bone marrow failure syndromes
- (2008) Takahiro Suzuki et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Overview of guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload
- (2008) Norbert Gattermann INTERNATIONAL JOURNAL OF HEMATOLOGY
- Factors Affecting Response and Survival in Patients With Myelodysplasia Treated With Immunosuppressive Therapy
- (2008) Elaine M. Sloand et al. JOURNAL OF CLINICAL ONCOLOGY
- Iron overload in myelodysplastic syndromes: A Canadian consensus guideline
- (2008) Richard A. Wells et al. LEUKEMIA RESEARCH
- Clinical Relevance of Anemia and Transfusion Iron Overload in Myelodysplastic Syndromes
- (2008) M. Cazzola et al. Hematology-American Society of Hematology Education Program
- Flow cytometry in myelodysplastic syndromes: Report from a working conference
- (2007) Michael R. Loken et al. LEUKEMIA RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started